Skip to main content
Erschienen in: World Journal of Surgery 5/2018

12.10.2017 | Original Scientific Report

The Clinical Implications of Liver Resection Margin Size in Patients with Hepatocellular Carcinoma in Terms of Positron Emission Tomography Positivity

verfasst von: Jae Hyun Park, Dong Hwi Kim, Sung Hoon Kim, Moon Young Kim, Soon Koo Baik, In Su Hong

Erschienen in: World Journal of Surgery | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The positivity of positron emission tomography (PET) in hepatocellular carcinoma (HCC) correlates with aggressive tumor factors and poor survival. Adequate resection margin size is still a topic of debate. We analyzed the clinical implications of resection margin size in patients with HCC in terms of PET positivity.

Methods

We retrospectively reviewed the medical records of 92 patients who underwent liver resection from March 2012 to October 2015. We investigated prognostic factors for recurrence and survival. We analyzed the correlation of resection margin size and PET positivity. Resection margins were classified as less than 1 cm and more than 1 cm.

Results

Twenty six (31.3%) patients had PET-positive HCC. Multivariate analysis showed PET, satellite nodules, microvessel invasion, and multicentric occurrence were significant prognostic factors for HCC recurrence. Multivariate analysis also showed satellite nodules and microscopic portal vein invasion were significant prognostic factors for overall survival (OS). Resection margin size did not affect disease-free survival (DFS) (p = 0.681) or OS (p = 0.301) in patients with PET-negative HCC, but showed a difference in DFS [<1 cm at 11 months vs. ≥1 cm at 41 months (p = 0.188)] and OS [<1 cm at 28 months vs. ≥1 cm at 48 months (p < 0.001)] in patients with PET-positive HCC.

Conclusions

PET has low sensitivity for HCC. However, it is useful to predict treatment outcomes after liver resection or liver transplantation for HCC. Although the extent of liver resection must be decided based on liver function, a resection margin size >1 cm may improve DFS and OS in patients with PET-positive HCC.
Literatur
1.
Zurück zum Zitat Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. The Lancet 379(1245–125):5 Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. The Lancet 379(1245–125):5
2.
Zurück zum Zitat European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943 European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943
3.
Zurück zum Zitat Korean Liver Cancer Study Group (KLCSG), National Cancer Center, Korea (NCC) (2015) 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma. Gut Liver 9:267–317 Korean Liver Cancer Study Group (KLCSG), National Cancer Center, Korea (NCC) (2015) 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma. Gut Liver 9:267–317
5.
Zurück zum Zitat Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol 35:421–430CrossRefPubMed Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol 35:421–430CrossRefPubMed
6.
Zurück zum Zitat Kokudo ND, Hasegawa K, Akahane M et al (2015) Evidence-based clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res 45:123–127CrossRef Kokudo ND, Hasegawa K, Akahane M et al (2015) Evidence-based clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res 45:123–127CrossRef
7.
Zurück zum Zitat Omata M, Lesmana LA, Tateishi R et al (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4(439–47):4 Omata M, Lesmana LA, Tateishi R et al (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4(439–47):4
8.
Zurück zum Zitat Yu SJ (2016) A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010–2016. Clin Mol Hepatol 22:7–17CrossRefPubMedPubMedCentral Yu SJ (2016) A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010–2016. Clin Mol Hepatol 22:7–17CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Poon RTP, Sheung TF, Chung ML et al (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373–382CrossRefPubMedPubMedCentral Poon RTP, Sheung TF, Chung ML et al (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373–382CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Proneth A, Zeman F, Schlitt HJ et al (2014) Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis. Ann Surg Oncol 21:3096–3107CrossRefPubMed Proneth A, Zeman F, Schlitt HJ et al (2014) Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis. Ann Surg Oncol 21:3096–3107CrossRefPubMed
11.
Zurück zum Zitat Bhangui P, Allard MA, Vibert E et al (2016) Salvage versus primary liver transplantation for early hepatocellular carcinoma: Do both strategies yield similar outcomes? Ann Surg 264:155–163CrossRefPubMed Bhangui P, Allard MA, Vibert E et al (2016) Salvage versus primary liver transplantation for early hepatocellular carcinoma: Do both strategies yield similar outcomes? Ann Surg 264:155–163CrossRefPubMed
12.
Zurück zum Zitat Chan DL, Alzahrani NA, Morris DL et al (2014) Systematic review of efficacy and outcomes of salvage liver transplantation after primary hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 29:31–41CrossRefPubMed Chan DL, Alzahrani NA, Morris DL et al (2014) Systematic review of efficacy and outcomes of salvage liver transplantation after primary hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 29:31–41CrossRefPubMed
13.
Zurück zum Zitat Agrawal S, Belghiti J (2011) Oncologic resection for malignant tumors of the liver. Ann Surg 253:656–665CrossRefPubMed Agrawal S, Belghiti J (2011) Oncologic resection for malignant tumors of the liver. Ann Surg 253:656–665CrossRefPubMed
14.
Zurück zum Zitat Shi M, Guo RP, Lin XJ et al (2007) Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245:36–43CrossRefPubMedPubMedCentral Shi M, Guo RP, Lin XJ et al (2007) Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245:36–43CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Park JW, Ji HK, Seok KK et al (2008) A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49:1912–1921CrossRefPubMed Park JW, Ji HK, Seok KK et al (2008) A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49:1912–1921CrossRefPubMed
16.
Zurück zum Zitat Kobayashi T, Aikata H, Honda F et al (2016) Preoperative fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for prediction of microvascular invasion in small hepatocellular carcinoma. J Comput Assist Tomogr 40:524–530CrossRefPubMed Kobayashi T, Aikata H, Honda F et al (2016) Preoperative fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for prediction of microvascular invasion in small hepatocellular carcinoma. J Comput Assist Tomogr 40:524–530CrossRefPubMed
17.
Zurück zum Zitat Asman Y, Evenson AR, Even-Sapir E et al (2015) [18F] fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma. Liver Transp 21:572–580CrossRef Asman Y, Evenson AR, Even-Sapir E et al (2015) [18F] fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma. Liver Transp 21:572–580CrossRef
18.
Zurück zum Zitat Ahn SG, Jeon TJ, Lee SD et al (2013) A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function Eur. J Surg Oncol 39:964–973CrossRef Ahn SG, Jeon TJ, Lee SD et al (2013) A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function Eur. J Surg Oncol 39:964–973CrossRef
19.
Zurück zum Zitat Lee HW, Suh K-S (2016) Liver transplantation for advanced hepatocellular carcinoma. Clin Mol Hepatol 22(309–31):8 Lee HW, Suh K-S (2016) Liver transplantation for advanced hepatocellular carcinoma. Clin Mol Hepatol 22(309–31):8
20.
Zurück zum Zitat Eguchi S, Kanematsu T, Arii S et al (2008) Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 143:469–475CrossRefPubMed Eguchi S, Kanematsu T, Arii S et al (2008) Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 143:469–475CrossRefPubMed
21.
Zurück zum Zitat Makuuchi M (2013) Surgical treatment for HCC—special reference to anatomical resection. Int J Surg 11:S47–S49CrossRefPubMed Makuuchi M (2013) Surgical treatment for HCC—special reference to anatomical resection. Int J Surg 11:S47–S49CrossRefPubMed
22.
Zurück zum Zitat Castilla-Lièvre MA, Franco D, Gervais P et al (2016) Diagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 43:852–859CrossRefPubMed Castilla-Lièvre MA, Franco D, Gervais P et al (2016) Diagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 43:852–859CrossRefPubMed
23.
Zurück zum Zitat Rodríguez-Perálvarez M, Luong TV, Andreana L et al (2013) A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol 20(325–33):9 Rodríguez-Perálvarez M, Luong TV, Andreana L et al (2013) A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol 20(325–33):9
24.
Zurück zum Zitat Kim BK, Kang WJ, Kim JK et al (2011) 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma. Cancer 117:4779–4787CrossRefPubMed Kim BK, Kang WJ, Kim JK et al (2011) 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma. Cancer 117:4779–4787CrossRefPubMed
25.
Zurück zum Zitat Bailly M, Venel Y, Orain I et al (2016) 18F-FDG PET in liver transplantation setting of hepatocellular carcinoma predicting histology? Clin Nucl Med 41:e126–e129CrossRefPubMed Bailly M, Venel Y, Orain I et al (2016) 18F-FDG PET in liver transplantation setting of hepatocellular carcinoma predicting histology? Clin Nucl Med 41:e126–e129CrossRefPubMed
26.
Zurück zum Zitat Hyun SH, Eo JS, Lee JW et al (2016) Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with barcelona clinic liver cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study. Eur J Nucl Med Mol Imaging 43:1638–1645CrossRefPubMed Hyun SH, Eo JS, Lee JW et al (2016) Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with barcelona clinic liver cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study. Eur J Nucl Med Mol Imaging 43:1638–1645CrossRefPubMed
27.
Zurück zum Zitat Min JH, Kim YK, Lim S et al (2015) Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: impact of intra-tumoral fat detected on chemical-shift images. Eur J Radiol 84:1036–1043CrossRefPubMed Min JH, Kim YK, Lim S et al (2015) Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: impact of intra-tumoral fat detected on chemical-shift images. Eur J Radiol 84:1036–1043CrossRefPubMed
Metadaten
Titel
The Clinical Implications of Liver Resection Margin Size in Patients with Hepatocellular Carcinoma in Terms of Positron Emission Tomography Positivity
verfasst von
Jae Hyun Park
Dong Hwi Kim
Sung Hoon Kim
Moon Young Kim
Soon Koo Baik
In Su Hong
Publikationsdatum
12.10.2017
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 5/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4275-1

Weitere Artikel der Ausgabe 5/2018

World Journal of Surgery 5/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.